CBDMD INC
YCBDNYSE AMERICANTrading Snapshot
- Day Range
- $0.46 – $0.47
- 52-Week Range
- $0.41 – $2.56
- Volume
- $2.44B
- Avg Volume
- $2.47B
- Shares Outstanding
- 10.5M
- Next Earnings
- Nov 16, 2026
Fundamentals Snapshot
- Annual Revenue
- $19M
- Last Q Revenue
- $6M
- P/E Ratio
- -1.5
- P/S Ratio
- 0.2x
- EPS (TTM)
- $-0.27
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +97.8%
Why Investors Own YCBD
- ✓High-growth profile — revenue up +42.8% YoY with expanding US Equity exposure.
- ✓Healthy economics — 76% gross margin and 20% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
CBDMD INC
YCBD
StockOtter · stockotter.spaceAbout CBDMD INC
cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
CBDMD INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift YCBD price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
CBDMD INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.